Delays in Approval of Injectable Medications for Diabetics
April 22, 2026
Diabetics and their doctors are expressing frustration over the delays in the approval of injectable medications by the health insurance agency, OAY. Increasing waiting times are causing interruptions in treatment or unsuitable dosages, which seriously affects patients' health. Some doctors report that the approval processes are slower for diabetes medications compared to others. Even automated procedures for chronic medications require renewals that complicate the situation. If this continues, it could severely impact the quality of life for diabetic patients.